(UTHR) United Therapeutics - Performance 29.3% in 12m
Compare UTHR with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
75.50%
#5 in Group
Rel. Strength
81.79%
#1454 in Universe
Total Return 12m
29.34%
#37 in Group
Total Return 5y
170.83%
#16 in Group
P/E 12.1
45th Percentile in Group
P/E Forward 10.6
42th Percentile in Group
PEG 1.43
88th Percentile in Group
FCF Yield 10.2%
98th Percentile in Group
12m Total Return: UTHR (29.3%) vs XBI (-1.8%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-1.68% | 29.3% | 171% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
-0.23% | 21% | 41.1% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-6.62% | 9.44% | 46.9% | 37 | 13.4 | 0.94 | -42.0% | -25.9% |
LONN SW Lonza |
8.56% | 16.2% | 38.7% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
3.94% | 19.8% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
-2.63% | -21.7% | 8.36% | 32.4 | 21.5 | 0.27 | 64.4% | 51.8% |
KMDA NASDAQ Kamada |
-2.12% | 27.5% | -10.6% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
14% | -1.49% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
Performance Comparison: UTHR vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for UTHR
Total Return (including Dividends) | UTHR | XBI | S&P 500 |
---|---|---|---|
1 Month | -1.68% | 2.28% | -0.87% |
3 Months | -13.69% | -10.48% | -7.58% |
12 Months | 29.34% | -1.83% | 11.88% |
5 Years | 170.83% | -12.72% | 110.33% |
Trend Score (consistency of price movement) | UTHR | XBI | S&P 500 |
1 Month | 2.60% | 56.6% | 23% |
3 Months | -87.0% | -89.3% | -88.5% |
12 Months | 28.1% | -42.4% | 55.1% |
5 Years | 91.5% | -53.6% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #122 | -3.87% | -0.82% |
3 Month | #83 | -3.58% | -6.61% |
12 Month | #37 | 31.8% | 15.6% |
5 Years | #15 | 210% | 28.8% |
FAQs
Does UTHR United Therapeutics outperforms the market?
Yes,
over the last 12 months UTHR made 29.34%, while its related Sector, the SPDR S&P Biotech (XBI) made -1.83%.
Over the last 3 months UTHR made -13.69%, while XBI made -10.48%.
Over the last 3 months UTHR made -13.69%, while XBI made -10.48%.
Performance Comparison UTHR vs Indeces and Sectors
UTHR vs. Indices UTHR is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -0.29% | -0.81% | -17.1% | 17.5% |
US NASDAQ 100 | QQQ | -1.32% | -3.08% | -17.5% | 16.7% |
US Dow Jones Industrial 30 | DIA | 0.65% | 1.50% | -17.0% | 20.1% |
German DAX 40 | DAX | 0.94% | -3.0% | -36.6% | 4.66% |
Shanghai Shenzhen CSI 300 | CSI 300 | 3.67% | 1.14% | -14.1% | 23.4% |
Hongkong Hang Seng | HSI | 0.70% | -1.74% | -19.0% | 15.5% |
India NIFTY 50 | INDA | 2.55% | -5.74% | -17.4% | 26.3% |
Brasil Bovespa | EWZ | 0.51% | -6.28% | -20.8% | 35.2% |
UTHR vs. Sectors UTHR is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -0.54% | -0.63% | -23.2% | 5.38% |
Consumer Discretionary | XLY | -0.37% | -1.58% | -19.6% | 16.0% |
Consumer Staples | XLP | 3.21% | -1.88% | -22.4% | 18.1% |
Energy | XLE | 4.19% | 12.2% | -11.3% | 40.4% |
Financial | XLF | 1.10% | 0.43% | -24.7% | 6.65% |
Health Care | XLV | -0.21% | 2.11% | -15.4% | 27.6% |
Industrial | XLI | -0.71% | -1.79% | -17.8% | 19.8% |
Materials | XLB | 0.32% | 0.75% | -9.68% | 32.9% |
Real Estate | XLRE | 1.23% | -0.37% | -16.2% | 11.3% |
Technology | XLK | -2.74% | -3.37% | -13.8% | 21.6% |
Utilities | XLU | 2.55% | -1.74% | -19.2% | 7.51% |
Aerospace & Defense | XAR | -1.24% | -8.07% | -30.6% | 2.77% |
Biotech | XBI | -1.59% | -3.96% | -4.45% | 31.2% |
Homebuilder | XHB | 0.40% | 0.59% | -2.28% | 36.4% |
Retail | XRT | 1.28% | -1.12% | -11.5% | 32.1% |